These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19818058)

  • 1. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
    Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
    Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial.
    Spronk S; Bosch JL; den Hoed PT; Veen HF; Pattynama PM; Hunink MG
    J Vasc Surg; 2008 Dec; 48(6):1472-80. PubMed ID: 18771879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.
    Bronas UG; Hirsch AT; Murphy T; Badenhop D; Collins TC; Ehrman JK; Ershow AG; Lewis B; Treat-Jacobson DJ; Walsh ME; Oldenburg N; Regensteiner JG;
    Vasc Med; 2009 Nov; 14(4):313-21. PubMed ID: 19808716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
    de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
    Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.
    Reynolds MR; Apruzzese P; Galper BZ; Murphy TP; Hirsch AT; Cutlip DE; Mohler ER; Regensteiner JG; Cohen DJ
    J Am Heart Assoc; 2014 Nov; 3(6):e001233. PubMed ID: 25389284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial.
    Djerf H; Millinger J; Falkenberg M; Jivegård L; Svensson M; Nordanstig J
    Circ Cardiovasc Interv; 2020 Jan; 13(1):e008450. PubMed ID: 31937137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease.
    Mazari FA; Khan JA; Carradice D; Samuel N; Gohil R; McCollum PT; Chetter IC
    Br J Surg; 2013 Aug; 100(9):1172-9. PubMed ID: 23842831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of information analysis optimizing future trial design from a pilot study on catheter securement devices.
    Tuffaha HW; Reynolds H; Gordon LG; Rickard CM; Scuffham PA
    Clin Trials; 2014 Dec; 11(6):648-56. PubMed ID: 25084784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication.
    van den Houten MM; Lauret GJ; Fakhry F; Fokkenrood HJ; van Asselt AD; Hunink MG; Teijink JA
    Br J Surg; 2016 Nov; 103(12):1616-1625. PubMed ID: 27513296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Would a Large tPA Trial for Those 4.5 to 6.0 Hours from Stroke Onset Be Good Value for Information?
    Soeteman DI; Menzies NA; Pandya A
    Value Health; 2017; 20(7):894-901. PubMed ID: 28712618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.
    Murphy TP; Hirsch AT; Ricotta JJ; Cutlip DE; Mohler E; Regensteiner JG; Comerota AJ; Cohen DJ;
    J Vasc Surg; 2008 Jun; 47(6):1356-63. PubMed ID: 18440181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant savings with a stepped care model for treatment of patients with intermittent claudication.
    Fokkenrood HJ; Scheltinga MR; Koelemay MJ; Breek JC; Hasaart F; Vahl AC; Teijink JA
    Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):423-9. PubMed ID: 24951374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of exercise therapy in patients with intermittent claudication: supervised exercise therapy versus a 'go home and walk' advice.
    van Asselt AD; Nicolaï SP; Joore MA; Prins MH; Teijink JA;
    Eur J Vasc Endovasc Surg; 2011 Jan; 41(1):97-103. PubMed ID: 21159527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular intervention for treatment of claudication: is it cost-effective?
    O'Brien-Irr MS; Harris LM; Dosluoglu HH; Dryjski ML
    Ann Vasc Surg; 2010 Aug; 24(6):833-40. PubMed ID: 20638623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How much is another randomized trial of lymph node dissection in endometrial cancer worth? A value of information analysis.
    Havrilesky LJ; Chino JP; Myers ER
    Gynecol Oncol; 2013 Oct; 131(1):140-6. PubMed ID: 23800699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using value of information methods to determine the optimal sample size for effectiveness trials of alcohol interventions for HIV-infected patients in East Africa.
    Li L; Uyei J; Nucifora KA; Kessler J; Stevens ER; Bryant K; Braithwaite RS
    BMC Health Serv Res; 2018 Jul; 18(1):590. PubMed ID: 30064428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of value of information: best informing research design and prioritization using current methods.
    Eckermann S; Karnon J; Willan AR
    Pharmacoeconomics; 2010; 28(9):699-709. PubMed ID: 20629473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials.
    Sadatsafavi M; Marra C; Bryan S
    Health Econ; 2013 Jul; 22(7):877-82. PubMed ID: 22933363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events.
    Basu A; Meltzer D
    Med Decis Making; 2018 May; 38(4):427-438. PubMed ID: 29529923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.